Avinger Inc Overview
Pro stress-test →Avinger is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD). The company's proprietary Lumivascular platform integrates optical coherence tomography with interventional catheters to provide real-time intravascular imaging guidance during minimally invasive procedures.
Strategic Profile
Pro stress-test →Avinger focused on high-margin image-guided atherectomy and chronic total occlusion (CTO) crossing devices serving interventional cardiologists and endovascular specialists. However, the company faced severe financial distress.
Competitive Landscape
Pro stress-test →Avinger competed against larger, better-capitalized vascular intervention companies including Angiodynamics, Atricure, Penumbra, Cook Biotech, and Terumo Medical. These competitors had significantly greater resources, established market presence, and diversified product portfolios, making it difficult for the micro-cap Avinger to achieve category penetration against better-funded rivals.
Industry Context
Avinger Inc operates in Medical Devices - Vascular Intervention/Cardiology.
Key facts
Founded: 2007 · Headquarters: Redwood City, US · Employees: 72 · Revenue: $7.26M · Market cap: Liquidated (Feb 2025)